PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-40.74%
Negative net income growth while CRWD stands at 30.05%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-8.54%
Negative yoy D&A while CRWD is 6.21%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-16516.67%
Negative yoy deferred tax while CRWD stands at 61.99%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
186.92%
Slight usage while CRWD is negative at -200.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
320.96%
Growth well above CRWD's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-114.12%
Negative yoy while CRWD is 14.15%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
33.59%
Some CFO growth while CRWD is negative at -13.35%. John Neff would note a short-term liquidity lead over the competitor.
-2.99%
Negative yoy CapEx while CRWD is 64.44%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition growth of 100.00% while CRWD is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
9.03%
Less growth in investment purchases vs. CRWD's 31.64%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-2.00%
Both yoy lines are negative, with CRWD at -36.63%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
48.00%
Investing outflow well above CRWD's 52.10%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-72.81%
Both yoy lines negative, with CRWD at -200.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
30.14%
Buyback growth of 30.14% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.